Cargando…

Evaluation and Prediction of Treatment Response for Hepatocellular Carcinoma

The incidence of hepatocellular carcinoma (HCC) is still on the rise in North America and Europe and is the second leading cause of cancer-related mortality. The treatment of HCC varies, with surgery and locoregional therapy (LRT) such as radiofrequency ablation and transcatheter arterial chemoembol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsujita, Yushi, Sofue, Keitaro, Ueshima, Eisuke, Ueno, Yoshiko, Hori, Masatoshi, Tsurusaki, Masakatsu, Murakami, Takamichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Japanese Society for Magnetic Resonance in Medicine 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086401/ https://www.ncbi.nlm.nih.gov/pubmed/36792205 http://dx.doi.org/10.2463/mrms.rev.2022-0118

Ejemplares similares

Clinical Application of Quantitative MR Imaging in Nonalcoholic Fatty Liver Disease
por: Tsujita, Yushi, et al.
Publicado: (2022)

Improved diagnosis of histological capsule in hepatocallular carcinoma by using nonenhancing capsule appearance in addition to enhancing capsule appearance in gadoxetic acid-enhanced MRI
por: Nishioka, Eiko, et al.
Publicado: (2023)

Diagnosis of Hepatocellular Carcinoma Using Gd-EOB-DTPA MR Imaging
por: Murakami, Takamichi, et al.
Publicado: (2021)

Dual-Energy Computed Tomography of the Liver: Uses in Clinical Practices and Applications
por: Tsurusaki, Masakatsu, et al.
Publicado: (2021)

Three-Dimensional Radiological Assessment of Ablative Margins in Hepatocellular Carcinoma: Pilot Study of Overlay Fused CT/MRI Imaging with Automatic Registration
por: Minami, Yasunori, et al.
Publicado: (2021)

Clinical utility of imaging for evaluation of hepatocellular carcinoma
por: Murakami, Takamichi, et al.
Publicado: (2014)

Hypervascular Benign and Malignant Liver Tumors That Require Differentiation from Hepatocellular Carcinoma: Key Points of Imaging Diagnosis
por: Murakami, Takamichi, et al.
Publicado: (2014)

Transarterial Chemoebolization in Hepatocellular Carcinoma: A Binational Japanese-German Study
por: Auer, Timo A, et al.
Publicado: (2022)

Plug-assisted Retrograde Transvenous Obliteration-II for Gastric Varices: A Case Report
por: Tsurusaki, Masakatsu, et al.
Publicado: (2023)

The feasibility of transcatheter arterial chemoembolization following radiation therapy for hepatocellular carcinoma
por: Hamada, Mostafa, et al.
Publicado: (2021)

Extraluminal recanalization for postoperative biliary obstruction using transseptal needle
por: Horinouchi, Hiroki, et al.
Publicado: (2020)

Do the variations in ROI placement technique have influence for prostate ADC measurements?
por: Ueno, Yoshiko, et al.
Publicado: (2022)

Present and future roles of FDG-PET/CT imaging in the management of gastrointestinal cancer: an update
por: Kitajima, Kazuhiro, et al.
Publicado: (2017)

Diagnostic performance of zero-TE lung MR imaging in FDG PET/MRI for pulmonary malignancies
por: Zeng, Feibi, et al.
Publicado: (2020)

Efficacy of superselective transcatheter arterial embolization for intractable postpartum hemorrhage due to genital tract trauma after vaginal delivery
por: Sasaki, Koji, et al.
Publicado: (2021)

Transcatheter arterial embolization for hemothorax caused by spinal fracture without arterial injury: a case report and review of the literature
por: Matsunaga, Naoki, et al.
Publicado: (2022)

Magnetic resonance imaging of intraocular optic nerve disorders: review article
por: Kanda, Tomonori, et al.
Publicado: (2020)

Physiological skin FDG uptake: A quantitative and regional distribution assessment using PET/MRI
por: Nogami, Munenobu, et al.
Publicado: (2021)

Clinical application of 18F-fluorodeoxyglucose positron emission tomography for assessment and evaluation after therapy for malignant hepatic tumor
por: Tsurusaki, Masakatsu, et al.
Publicado: (2013)

In vivo evaluation of percutaneous carbon dioxide treatment for improving intratumoral hypoxia using (18)F-fluoromisonidazole PET-CT
por: Maruyama, Koji, et al.
Publicado: (2021)

Exploratory Analysis of Lenvatinib Therapy in Patients with Unresectable Hepatocellular Carcinoma Who Have Failed Prior PD−1/PD-L1 Checkpoint Blockade
por: Aoki, Tomoko, et al.
Publicado: (2020)

Transcatheter Arterial Embolization Treatment for Bleeding Visceral Artery Pseudoaneurysms in Patients with Pancreatitis or following Pancreatic Surgery
por: Numoto, Isao, et al.
Publicado: (2020)

Correction: Isao N., et al. Transcatheter Arterial Embolization Treatment for Bleeding Visceral Artery Pseudoaneurysms in Patients with Pancreatitis or Following Pancreatic Surgery. Cancers 2020, 12, 2733
por: Numoto, Isao, et al.
Publicado: (2021)

Computed Diffusion-Weighted Imaging in Prostate Cancer: Basics, Advantages, Cautions, and Future Prospects
por: Ueno, Yoshiko R., et al.
Publicado: (2018)

Comparison of Conventional Imaging and 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Diagnostic Accuracy of Staging in Patients with Intrahepatic Cholangiocarcinoma
por: Nishioka, Eiko, et al.
Publicado: (2022)

Comparative study of sub-second temporal resolution 4D-MRI and 4D-CT for target motion assessment in a phantom model
por: Wang, Tianyuan, et al.
Publicado: (2023)

Prediction of pancreatic atrophy after steroid therapy using equilibrium‐phase contrast computed tomography imaging in autoimmune pancreatitis
por: Yamada, Yasutaka, et al.
Publicado: (2020)

Pre-Operative Imaging and Pathological Diagnosis of Localized High-Grade Pancreatic Intra-Epithelial Neoplasia without Invasive Carcinoma
por: Sagami, Ryota, et al.
Publicado: (2021)

Role of Diffusion Weighted Imaging and Contrast-Enhanced MRI in the Evaluation of Intrapelvic Recurrence of Gynecological Malignant Tumor
por: Kitajima, Kazuhiro, et al.
Publicado: (2015)

Comparison of systems for assessment of post-therapeutic response to sorafenib for hepatocellular carcinoma
por: Arizumi, Tadaaki, et al.
Publicado: (2014)

Activation of JNK and high expression level of CD133 predict a poor response to sorafenib in hepatocellular carcinoma
por: Hagiwara, S, et al.
Publicado: (2012)

Targeted and immune therapies for hepatocellular carcinoma: Predictions for 2019 and beyond
por: Kudo, Masatoshi
Publicado: (2019)

Role of β-Catenin Activation in the Tumor Immune Microenvironment and Immunotherapy of Hepatocellular Carcinoma
por: Morita, Masahiro, et al.
Publicado: (2023)

Preliminary Study of a Single Instillation of Low-Concentration High-Volume Silver Nitrate Solution for Chyluria: Is >10 mL Instillation an Absolute Contraindication in the Real World?
por: Mitsunari, Kensuke, et al.
Publicado: (2019)

The usefulness of the total metabolic tumor volume for predicting the postoperative recurrence of thoracic esophageal squamous cell carcinoma
por: Kaida, Hayato, et al.
Publicado: (2022)

Evaluation of Response to Atezolizumab Plus Bevacizumab in Patients with Advanced Hepatocellular Carcinoma Using the Combination of Response Evaluation Criteria in Solid Tumors and Alpha-Fetoprotein
por: Kinami, Takahiro, et al.
Publicado: (2023)

Conventional or Drug-Eluting Beads? Randomized Controlled Study of Chemoembolization for Hepatocellular Carcinoma: JIVROSG-1302
por: Ikeda, Masafumi, et al.
Publicado: (2022)

Transitions of Liver and Biliary Enzymes during Proton Beam Therapy for Hepatocellular Carcinoma
por: Sumiya, Taisuke, et al.
Publicado: (2020)

Analysis of Survival and Response to Lenvatinib in Unresectable Hepatocellular Carcinoma
por: Amioka, Kei, et al.
Publicado: (2022)

Advanced hepatocellular carcinoma with response to lenvatinib after atezolizumab plus bevacizumab
por: Yano, Shigeki, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_u2stkd09g4q0q44cms6n23iehd